<?xml version="1.0" encoding="UTF-8"?>
<title-group>
 <article-title>PRIME-HCC: phase Ib study of neoadjuvant ipilimumab and nivolumab prior to liver resection for hepatocellular carcinoma</article-title>
</title-group>
